These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37441401)

  • 1. Cardiac magnetic resonance of hypertrophic heart phenotype: A review.
    Tore D; Faletti R; Gaetani C; Bozzo E; Biondo A; Carisio A; Menchini F; Miccolis M; Papa FP; Trovato M; Fonio P; Gatti M
    Heliyon; 2023 Jun; 9(6):e17336. PubMed ID: 37441401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management.
    Licordari R; Trimarchi G; Teresi L; Restelli D; Lofrumento F; Perna A; Campisi M; de Gregorio C; Grimaldi P; Calabrò D; Costa F; Versace AG; Micari A; Aquaro GD; Di Bella G
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Ventricular Hypertrophy: Evaluation With Cardiac MRI.
    Grajewski KG; Stojanovska J; Ibrahim EH; Sayyouh M; Attili A
    Curr Probl Diagn Radiol; 2020; 49(6):460-475. PubMed ID: 31630875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Diagnosis of Thick Myocardium according to Histologic Features Revealed by Multiparametric Cardiac Magnetic Resonance Imaging.
    Cha MJ; Kim C; Park CH; Hong YJ; Shin JM; Kim TH; Cha YJ; Park CH
    Korean J Radiol; 2022 Jun; 23(6):581-597. PubMed ID: 35555885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):13. PubMed ID: 22296938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
    Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease.
    Deva DP; Hanneman K; Li Q; Ng MY; Wasim S; Morel C; Iwanochko RM; Thavendiranathan P; Crean AM
    J Cardiovasc Magn Reson; 2016 Mar; 18():14. PubMed ID: 27036375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
    Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
    Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy.
    Lavall D; Vosshage NH; Geßner R; Stöbe S; Ebel S; Denecke T; Hagendorff A; Laufs U
    Clin Res Cardiol; 2023 Mar; 112(3):334-342. PubMed ID: 35355115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Duarte S; Bogaert J
    Rev Port Cardiol; 2010 Jan; 29(1):79-93. PubMed ID: 20391901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotyping of hypertensive heart disease and hypertrophic cardiomyopathy using personalized 3D modelling and cardiac cine MRI.
    Chuah SH; Md Sari NA; Chew BT; Tan LK; Chiam YK; Chan BT; Lim E; Abdul Aziz YF; Liew YM
    Phys Med; 2020 Oct; 78():137-149. PubMed ID: 33007738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
    Rickers C; Wilke NM; Jerosch-Herold M; Casey SA; Panse P; Panse N; Weil J; Zenovich AG; Maron BJ
    Circulation; 2005 Aug; 112(6):855-61. PubMed ID: 16087809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.
    Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Left Ventricular Hypertrophy, Small Pericardial Effusion, and Diffuse Late Gadolinium Enhancement by Cardiac Magnetic Resonance Suspecting Cardiac Amyloidosis: Endomyocardial Biopsy Reveals an Unexpected Diagnosis.
    Hofmann NP; Giusca S; Klingel K; Nunninger P; Korosoglou G
    Case Rep Cardiol; 2016; 2016():2461502. PubMed ID: 27247807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
    Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
    J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.